Musculoskeletal

Carpal tunnel syndrome: workup and management

Clinical Overview and When to Suspect Carpal Tunnel Syndrome

— Nocturnal hand paresthesias relieved by "flick sign" (shaking the hand)

— Numbness/tingling in thumb, index, middle, and radial half of ring finger

— Symptoms triggered by driving, holding a phone, reading

— Occupational exposure: repetitive wrist flexion/extension, vibratory tools, keyboard use (data mixed but classic stem)

— Pregnancy (3rd trimester, often bilateral, usually resolves postpartum)

— Diabetes mellitus, hypothyroidism, obesity (BMI >30)

— Rheumatoid arthritis, gout, amyloidosis (especially transthyretin amyloidosis — bilateral CTS may precede cardiac amyloid by years)

— Acromegaly, dialysis (β2-microglobulin amyloid), menopause

— Wrist trauma (Colles fracture), ganglion cysts

Board pearl: A 65-year-old man with bilateral CTS plus heart failure with preserved ejection fraction → suspect ATTR cardiac amyloidosis; order pyrophosphate scan and serum/urine immunofixation. This linkage is heavily tested on Step 3.

Step 3 management: CTS is largely an outpatient diagnosis — confirmed clinically. Reserve electrodiagnostic testing for atypical presentations, surgical planning, or when the diagnosis is unclear. Avoid premature MRI or extensive labs; instead, screen for the modifiable underlying conditions above (TSH, HbA1c) when the history suggests them. Early identification matters because delayed treatment of severe CTS leads to permanent thenar atrophy and functional disability.

Carpal tunnel syndrome (CTS) is a compressive median neuropathy at the wrist, where the median nerve traverses beneath the transverse carpal ligament alongside nine flexor tendons.

Most common entrapment neuropathy in the US; lifetime prevalence ~5–10%, peak incidence ages 40–60, female-to-male ratio ~3:1.

Pathophysiology: increased pressure in the carpal tunnel (>30 mmHg symptomatic, normal ~2–10 mmHg) → ischemia of median nerve → demyelination, then axonal loss if chronic.

When to suspect in ambulatory family medicine:

High-yield risk factors (memorize for boards):

Presentation Patterns and Key History

— Numbness/paresthesia in median nerve distribution (thumb, index, middle, radial half of ring finger) — palm spared because the palmar cutaneous branch arises proximal to the tunnel

— Nocturnal symptoms awakening the patient; relieved by shaking/dangling the hand ("flick sign")

— Pain that may radiate proximally to the forearm, even shoulder ("proximal radiation does not exclude CTS")

— Dropping objects (buttons, coins, keys) — suggests thenar weakness, more advanced disease

— Difficulty with fine motor tasks: opening jars, fastening buttons, writing

— Hand clumsiness, decreased grip strength

— Intermittent paresthesias → constant numbness → motor weakness/atrophy (late)

— Symptoms worse at night (wrist flexion during sleep) and with sustained postures

— Hand dominance and laterality (often bilateral but dominant side worse)

— Occupation: forceful repetitive grip, vibratory tools (jackhammer, chainsaw), prolonged wrist deviation

— Hobbies: knitting, gaming, racquet sports

— Comorbidities: DM, thyroid disease, RA, recent pregnancy, dialysis

— Medications: aromatase inhibitors (linked to CTS), bisphosphonates

— Trauma history: distal radius fracture, wrist sprain

— Red flags suggesting alternative diagnosis: neck pain (cervical radiculopathy), bilateral lower extremity symptoms (myelopathy), weight loss (mass effect)

Key distinction: Cervical radiculopathy (C6/C7) vs CTS — radiculopathy gives neck pain with radiation, symptoms reproduced by Spurling maneuver, and follows a dermatomal pattern that includes the shoulder/arm rather than respecting the median nerve at the wrist. A "double-crush syndrome" can coexist — both lesions on the same nerve pathway — and may explain incomplete response to carpal tunnel release.

Board pearl: Painless thenar wasting without sensory complaints argues against CTS and toward C8/T1 radiculopathy, ALS, or syringomyelia — refer for further neurologic evaluation rather than splinting.

Classic symptom triad:

Functional complaints to elicit:

Temporal pattern:

Targeted history checklist:

Physical Exam Findings and Provocative Testing

— Thenar atrophy (abductor pollicis brevis, opponens pollicis) — late finding, indicates axonal loss

— "Ape hand" deformity in severe chronic disease (loss of thumb opposition)

— Two-point discrimination (normal <6 mm at fingertip) — most sensitive for early disease loss

— Light touch (Semmes-Weinstein monofilament) — graded sensory threshold

— Palm sensation preserved (palmar cutaneous branch spared) — key differentiator

— Thumb abduction strength (APB) against resistance — patient lifts thumb perpendicular to palm

— Opposition (thumb to small finger) — assesses opponens pollicis

— Tinel sign: percussion over volar wrist → paresthesias in median distribution; sensitivity ~50%, specificity ~77%

— Phalen test: wrist flexion held 60 seconds → reproduces symptoms; sensitivity ~68%, specificity ~73%

— Durkan carpal compression test: direct pressure over carpal tunnel for 30 seconds — most sensitive (~64%) and specific (~83%) clinical test; preferred per recent AAOS guidelines

— Hand elevation test: arms raised above head for 1–2 min reproduces symptoms

— Flick sign: patient demonstrates shaking the hand for relief — high specificity when spontaneously volunteered

Board pearl: A negative Tinel/Phalen does not exclude CTS — these tests have only moderate sensitivity. Diagnosis remains primarily clinical when the symptom history is classic.

Step 3 management: In a typical outpatient stem with classic symptoms and supportive exam, the next step is nocturnal neutral wrist splinting, not nerve conduction studies. NCS is appropriate when surgery is contemplated, the diagnosis is uncertain, or atypical features are present.

Inspection:

Sensory testing in median distribution:

Motor testing:

Provocative maneuvers (memorize sensitivities/specificities):

Functional grading: Use CTS-6 clinical diagnostic criteria (numbness in median distribution, nocturnal symptoms, weakness/atrophy, Tinel, Phalen, loss of two-point discrimination) — high diagnostic accuracy without electrodiagnostics.

Diagnostic Workup — Initial Evaluation

— TSH if signs/symptoms of hypothyroidism (cold intolerance, weight gain, fatigue, bradycardia)

— HbA1c or fasting glucose if risk factors for diabetes (CTS is more common and more severe in diabetics)

— CBC, ESR/CRP if inflammatory arthritis suspected

— Pregnancy test if relevant

— Serum/urine immunofixation, free light chains, NT-proBNP, troponin, echocardiogram if bilateral CTS in elderly + cardiac symptoms → screen for amyloidosis

— Uric acid if tophaceous gout suspected

— Plain wrist radiographs: only if trauma history, deformity, or suspicion of arthritis/mass

— Ultrasound of the wrist: increasing utility; measures median nerve cross-sectional area at carpal tunnel inlet — >10 mm² supports CTS; sensitivity ~78%, specificity ~87%; useful for detecting masses, tenosynovitis, anatomic anomalies (bifid median nerve, persistent median artery)

— MRI: reserved for atypical cases, suspected mass, recurrent CTS post-surgery

Key distinction: Ultrasound vs nerve conduction studies — both have similar diagnostic accuracy for moderate CTS. Ultrasound is faster, cheaper, painless, and visualizes anatomy; NCS quantifies severity and confirms physiologic dysfunction. Many practices now use ultrasound as first-line confirmatory testing.

Board pearl: In a pregnant patient with classic bilateral CTS, no further workup is needed — initiate splinting, reassure that symptoms typically resolve within weeks to months postpartum, and avoid steroid injections unless severe.

Step 3 management: Do not order an MRI for typical CTS. Do not order EMG/NCS as a "screening" study — order it when the result will change management (surgical referral, severity grading, ruling out alternatives like ulnar neuropathy or radiculopathy).

Diagnosis is primarily clinical. Routine imaging and lab testing are not required for typical presentations.

When to order labs — guided by history:

Imaging — typically not first-line:

Cervical spine imaging: Only if exam suggests radiculopathy or myelopathy.

Electrodiagnostic Studies — Confirmatory Testing

— Atypical presentation (palm involvement, non-median distribution, bilateral motor weakness)

— Diagnostic uncertainty (overlap with cervical radiculopathy, polyneuropathy, ulnar neuropathy)

— Preoperative confirmation prior to surgical release

— Severity grading when it changes management urgency

— Failed conservative therapy with persistent symptoms

— Worker's compensation/disability documentation

— Prolonged distal motor latency of median nerve (>4.2 ms)

— Prolonged distal sensory latency and decreased sensory nerve action potential (SNAP) amplitude — typically the earliest abnormality

— Slowed conduction velocity across the wrist segment with preserved velocity proximally (focal slowing)

— Comparison studies (median vs ulnar sensory latency to ring finger; median vs radial to thumb) increase sensitivity for mild disease

— Fibrillations, positive sharp waves in APB

— Decreased motor unit recruitment, polyphasic motor units

— Mild: prolonged sensory latencies only

— Moderate: prolonged sensory + motor latencies, normal amplitudes

— Severe: decreased amplitudes, denervation on EMG, thenar atrophy

Board pearl: Up to 10–25% of clinically diagnosed CTS have normal NCS (false negatives, especially in early/mild disease). A normal study does not exclude CTS — treat the patient, not the number.

Key distinction: NCS distinguishes CTS from proximal median neuropathy (pronator syndrome), C6–C7 radiculopathy, brachial plexopathy, and generalized polyneuropathy (diabetic, uremic) — each has distinct electrodiagnostic patterns. Always test the contralateral side and adjacent nerves for context.

Nerve conduction studies (NCS) + electromyography (EMG) are the gold standard confirmatory test for CTS.

Indications for NCS/EMG:

Key NCS findings:

EMG findings (if motor axonal loss):

AAOS/AANEM severity grading:

Severity-Based Management Algorithm

— First-line: nocturnal neutral-position wrist splinting × 4–6 weeks

— Activity modification: avoid prolonged wrist flexion/extension, ergonomic adjustments

— Treat underlying conditions (hypothyroidism, diabetes optimization, weight loss)

— Reassess at 4–6 weeks; if improving, continue; if no improvement, escalate

— Continue splinting

— Corticosteroid injection into the carpal tunnel (not the nerve) — typically methylprednisolone 40 mg or triamcinolone

— Short course oral corticosteroids (prednisone 20 mg × 10–14 days) — moderate evidence, less preferred than injection

— Hand therapy/nerve gliding exercises (modest benefit)

— NSAIDs and diuretics — not effective (low-quality evidence; do not recommend)

— Surgical carpal tunnel release — definitive management

— Refer to hand surgery promptly; delay risks permanent axonal loss

— Surgical referral

— Oral NSAIDs alone, oral diuretics, vitamin B6 (pyridoxine), ultrasound therapy, yoga, magnets, laser

Step 3 management: A 45-year-old with 2 months of nocturnal hand paresthesias and positive Phalen — the next best step is nocturnal wrist splinting, not EMG, not injection, not surgery. Splinting for ≥4 weeks before escalating is the standard outpatient pathway.

Board pearl: Corticosteroid injection gives short-term relief (1–10 weeks for most); ~50% recur by 1 year. Use as a bridge while planning surgery or during pregnancy, not as definitive therapy.

CTS management is stratified by severity and chronicity — Step 3 questions often ask "what is the next best step" based on this framework.

Mild CTS (intermittent symptoms, no weakness, no atrophy, normal or mildly prolonged NCS):

Moderate CTS (frequent/constant symptoms, no significant weakness):

Severe CTS (constant numbness, thenar weakness/atrophy, denervation on EMG):

Failed conservative therapy (persistent symptoms after 6–12 weeks of splinting ± injection):

Therapies with weak or no evidence (avoid recommending on boards):

Pharmacotherapy and Injection Details

— Neutral-position (0°) wrist splint, prefabricated cock-up splint

— Worn at night; full-time wear adds modest benefit but lower adherence

— Effective in 40–60% of mild-moderate cases at 6 weeks

— Agents: methylprednisolone 40 mg or triamcinolone acetonide 40 mg, often mixed with 1% lidocaine

— Technique: ulnar to palmaris longus tendon, proximal to distal wrist crease, angled 30° distally; needle advances to just deep to flexor retinaculum, avoiding direct nerve contact

— Ultrasound guidance increases accuracy and reduces complications

— Repeat injection no more than 2–3 times due to risk of tendon rupture and nerve injury

— Efficacy: ~70% short-term improvement; 50% recurrence by 12 months

— Complications: median nerve injury (rare with guidance), tendon rupture, skin atrophy, transient hyperglycemia in diabetics, infection

— Prednisolone 20 mg daily × 10–14 days — modest short-term benefit

— Useful when injection contraindicated (needle-phobic patient, anticoagulation)

— Hand therapy with nerve/tendon gliding exercises

— Manual therapy and yoga — small RCTs suggest modest benefit

— Therapeutic ultrasound — mixed data

— Oral NSAIDs (no better than placebo for CTS)

— Diuretics

— Pyridoxine (vitamin B6) — historically used but no good evidence

Board pearl: In a diabetic patient, warn about a transient blood glucose spike for 24–72 hours after intra-articular or peri-tendinous steroid injection; counsel on monitoring and consider adjusting insulin.

Step 3 management: A patient with moderate CTS who failed 6 weeks of splinting → the next best step is carpal tunnel corticosteroid injection, not immediate surgical referral. If symptoms recur after a second injection or motor weakness develops, escalate to surgery.

Splinting (non-pharmacologic but first-line):

Local corticosteroid injection — the workhorse pharmacotherapy:

Oral corticosteroids:

Adjuncts with weak evidence (low priority on boards):

Ineffective therapies — do NOT choose on exam:

Surgical Management — Carpal Tunnel Release

— Severe CTS with motor weakness or thenar atrophy at presentation

— Persistent symptoms despite ≥6–12 weeks of conservative therapy (splinting ± injection)

— Denervation on EMG

— Recurrent symptoms after corticosteroid injection

— Acute CTS (post-traumatic, hematoma) — surgical emergency

— Open carpal tunnel release (OCTR): 3–4 cm palmar incision; transverse carpal ligament divided under direct visualization

— Endoscopic carpal tunnel release (ECTR): 1–2 small incisions; smaller scar, faster return to work (~1 week earlier)

— Outcomes at 1 year equivalent between approaches; ECTR has slightly higher (rare) transient nerve injury risk; OCTR has more incisional tenderness

— Same-day, ambulatory procedure under local anesthesia ± sedation

— 70–90% report significant symptom improvement

— Nocturnal symptoms typically resolve within days

— Numbness and motor function improve over weeks to months; severe long-standing atrophy may not fully recover

— Soft dressing 1–2 days; encourage early finger range of motion

— Avoid heavy lifting × 4–6 weeks

— Sutures removed at 10–14 days

— Return to desk work in 1–2 weeks; manual labor 4–6 weeks

— Pillar pain (palmar tenderness, 6 weeks–6 months), incomplete release, nerve injury (median, palmar cutaneous, recurrent motor branch), scar tenderness, CRPS, infection, hematoma

CCS pearl: For a patient admitted with acute CTS after distal radius fracture or carpal tunnel hematoma (e.g., anticoagulated), the move is urgent hand surgery consult for emergent decompression, hold/reverse anticoagulation as appropriate, neurovascular checks q2h, and elevate the limb.

Board pearl: Recurrence after CTR (5–15%) → re-image with ultrasound/MRI and consider revision; rule out incomplete release vs scar formation.

Carpal tunnel release (CTR) is the definitive treatment when conservative therapy fails or when severe disease is present at diagnosis.

Indications:

Surgical approaches:

Outcomes:

Postoperative care:

Complications (overall <5%):

Special Populations — Elderly, Renal, and Hepatic Considerations

— CTS often presents later and more severely (delayed care-seeking, multifactorial neuropathy)

— Bilateral CTS in elderly men → screen for transthyretin (ATTR) amyloidosis: order pyrophosphate scan, NT-proBNP, echocardiogram, serum/urine immunofixation with free light chains (to exclude AL amyloid)

— Coexisting cervical spondylosis and diabetic polyneuropathy complicate the picture — NCS often warranted

— Greater risk of permanent deficits if delayed; lower threshold for surgical referral

— Postoperative falls risk if dominant hand immobilized — arrange home support

— Hemodialysis patients are at high risk via β2-microglobulin amyloidosis depositing in the carpal tunnel

— AV fistula in the ipsilateral arm can contribute via venous hypertension and steal phenomenon — assess fistula function

— Avoid steroid injections in immunocompromised dialysis patients without strong indication; surgical release is often preferred for definitive management

— Adjust perioperative anticoagulation; dialyze the day before surgery, not the day of

— Few CTS-specific implications; ensure no coagulopathy before injection/surgery (check INR, platelets)

— Acetaminophen preferred over NSAIDs for postoperative pain in cirrhosis (max 2 g/day)

— Avoid gabapentinoids as first-line for CTS pain in elderly — limited efficacy, fall risk

— Topical NSAIDs or capsaicin acceptable adjuncts

Step 3 management: A 72-year-old dialysis patient with bilateral hand numbness, thenar atrophy, and a left AV fistula — order NCS, evaluate fistula, and refer for surgical carpal tunnel release rather than repeat steroid injections. Coordinate timing with the dialysis schedule.

Board pearl: Persistent or recurrent CTS in a patient with unexplained HFpEF, low-voltage ECG, or pseudo-infarct Q waves should prompt ATTR amyloid workup — this longitudinal connection is highly tested.

Elderly patients:

Chronic kidney disease / dialysis:

Hepatic impairment:

Polypharmacy considerations:

Special Populations — Pregnancy and Pediatrics

— Occurs in ~30–60% of pregnancies, peak in third trimester

— Bilateral, often more severe at night

— Etiology: fluid retention, increased extracellular volume, hormonal effects on connective tissue

— Diagnosis is clinical; avoid NCS unless atypical

— First-line: nocturnal neutral wrist splinting — safe, effective, no fetal risk

— Acetaminophen for pain; avoid NSAIDs in 3rd trimester (premature ductus closure, oligohydramnios)

— Corticosteroid injection: reserved for severe refractory cases; small data suggest safety

— Most cases resolve within weeks to months postpartum — reassure

— Persistent symptoms >6 months postpartum → reevaluate, consider NCS and surgical referral

— Lactation: splinting and CTR both compatible with breastfeeding; brief steroid exposure acceptable

— Rare; when present, suspect a systemic or genetic disorder:

— Mucopolysaccharidoses (Hurler, Hunter, Maroteaux-Lamy) — bilateral CTS, claw hand, skeletal dysplasia

— Trigger thumb/digit, congenital flexor tenosynovitis

— Familial CTS (autosomal dominant)

— Workup includes urine glycosaminoglycans, enzyme assays, and pediatric genetics referral

— Treatment: address underlying disorder; surgical release if symptomatic

— Overuse injuries (gymnasts, pianists, gamers) — ergonomic counseling and activity modification are key

Key distinction: Pregnancy CTS vs de Quervain tenosynovitis (radial wrist pain, positive Finkelstein test, also pregnancy-associated) — both common peripartum but different anatomy and treatment.

Board pearl: A child with bilateral CTS, coarse facies, hepatosplenomegaly, and corneal clouding → mucopolysaccharidosis. Refer for genetic testing and enzyme replacement therapy where applicable.

Step 3 management: For a 32-week pregnant woman with classic nocturnal CTS symptoms, the next step is reassurance, ergonomic counseling, and nocturnal neutral-position wrist splinting — not NCS, not injection, not surgery.

Pregnancy-related CTS:

Pediatric CTS:

Adolescent athletes/musicians:

Complications and Adverse Outcomes

— Permanent thenar atrophy and loss of thumb opposition (axonal loss)

— Chronic pain syndrome and complex regional pain syndrome (CRPS)

— Functional disability: difficulty with self-care, work, driving

— Workplace injury and accidents (dropping objects, hand burns from loss of sensation)

— Sleep disturbance and secondary mood disorders

— Median nerve injury — direct needle trauma, intraneural injection (avoid by injecting awake patient who reports paresthesias before injection)

— Tendon rupture (rare, more common with repeated injections)

— Local skin atrophy, fat necrosis, hypopigmentation

— Infection (rare, <1%)

— Transient hyperglycemia in diabetics

— Vasovagal syncope during procedure

— Pillar pain (palmar tenderness 6 weeks–6 months) — most common, self-limited

— Incomplete release → persistent symptoms; revise

— Injury to recurrent motor branch of median nerve → thenar weakness

— Injury to palmar cutaneous branch → painful neuroma at incision site

— Hypertrophic scar, keloid

— CRPS (1–5%)

— Infection (<1%), hematoma

— Bowstringing of flexor tendons (rare, late)

— Persistent or recurrent symptoms in 5–15%

— Repeat NCS; ultrasound/MRI of the wrist

— Consider incomplete release, scar tethering, alternative diagnosis (cervical radiculopathy, proximal median neuropathy), CRPS

CCS pearl: Post-CTR patient returns at 2 weeks with fever, swelling, erythema, drainage → diagnose surgical site infection; order wound culture and CBC, start empiric cefazolin or clindamycin, and arrange hand surgery follow-up within 24–48 hours. Hospitalize if systemic signs.

Board pearl: Severe burning pain, allodynia, color/temperature changes, and trophic skin changes after CTR → CRPS type I (no nerve injury) or type II (nerve injury). Refer to pain medicine and physical therapy early; consider gabapentinoids, bisphosphonates, and sympathetic blocks.

Complications of untreated/under-treated CTS:

Complications of corticosteroid injection:

Surgical complications:

Failed CTR workup:

When to Escalate — Specialist Referral and Inpatient Care

— Thenar atrophy or motor weakness on presentation

— Severe NCS findings with axonal loss

— Failure of 6–12 weeks of conservative therapy

— Recurrent symptoms after 2 steroid injections

— Recurrent CTS after prior release

— Acute CTS: rapidly progressive symptoms after wrist trauma, fracture, hematoma (anticoagulated patient), high-pressure injection injury, infection — surgical emergency for decompression

— Compartment syndrome of the hand/forearm — limb-threatening

— Atypical or diffuse symptoms suggesting polyneuropathy

— Coexisting suspected cervical radiculopathy or myelopathy

— Bilateral CTS without obvious cause

— Suspected motor neuron disease (asymmetric atrophy without sensory loss)

— RA, lupus, gout, or other inflammatory arthritis with hand involvement

— Bilateral CTS + HFpEF or low-voltage ECG → suspected cardiac amyloidosis; coordinate with cardiology

— Acromegaly suspicion (enlarging hands, jaw, ring/shoe size changes)

— Acute traumatic CTS: admit for serial neurovascular exams, urgent decompression, pain control

— Post-op infection with systemic signs: admit, IV antibiotics, hand surgery consult

Step 3 management: A patient on warfarin presents with sudden severe hand pain and worsening median paresthesias 6 hours after a fall — diagnose acute CTS from carpal tunnel hematoma; check INR, reverse anticoagulation (vitamin K + 4-factor PCC if INR elevated), call hand surgery for emergent release, do not splint and discharge.

CCS pearl: When a CCS case shows progressive median nerve symptoms post-trauma, the next orders are: neurovascular checks q1–2h, hand surgery STAT consult, elevate the limb, ice, IV analgesia, NPO, type and screen, pre-op labs.

CTS is overwhelmingly an outpatient diagnosis — inpatient escalation is rare but tested.

Refer to hand surgery (urgent, within 1–2 weeks):

Refer to hand surgery (emergent, same day):

Refer to neurology:

Refer to rheumatology:

Refer to cardiology/hematology:

Refer to endocrinology:

Inpatient triage:

Key Differentials — Other Neuropathies and Wrist Disorders

— Neck pain, radiation to arm; symptoms reproduced by Spurling maneuver

— Dermatomal distribution; reflex changes (biceps for C6, triceps for C7)

— MRI cervical spine; NCS/EMG with paraspinal involvement

— Median nerve compression at the pronator teres or fibrous arch

— Palmar sensation involved (palmar cutaneous branch arises distal to compression site) — key distinguishing feature

— Forearm pain, weakness of FDP to index finger and FPL

— No nocturnal symptoms; aggravated by resisted pronation

— Pure motor: weakness of FPL, FDP to index, pronator quadratus → "OK sign" cannot be made (Kiloh-Nevin sign)

— No sensory loss

— Numbness in ring (ulnar half) and small finger, weakness of intrinsics

— Froment sign positive

— Symptoms with overhead activity; supraclavicular tenderness; positive Adson, Roos tests

— Often C8/T1 distribution (medial arm/hand)

— Acute severe shoulder/arm pain followed by patchy weakness; viral or post-vaccination

— Radial wrist pain, positive Finkelstein; no neurologic symptoms

— Catching/locking digit; nodule at A1 pulley; not neuropathic

Key distinction: Palm involvement points away from CTS (which spares the palmar cutaneous branch) and toward proximal median neuropathy or cervical radiculopathy. This is a recurring board distractor.

Board pearl: Inability to make the "OK sign" (touching thumb tip to index fingertip in a circle) → anterior interosseous nerve syndrome, not CTS. Pure motor deficit, no sensory complaints.

Cervical radiculopathy (C6/C7):

Pronator syndrome (proximal median neuropathy):

Anterior interosseous nerve syndrome:

Ulnar neuropathy at the wrist (Guyon canal) or elbow (cubital tunnel):

Thoracic outlet syndrome:

Brachial plexopathy (Parsonage-Turner syndrome):

De Quervain tenosynovitis:

Trigger finger (stenosing flexor tenosynovitis):

Key Differentials — Systemic and Other-Category Causes

— Bilateral, symmetric, stocking-glove sensory loss; often coexists with CTS in diabetics

— NCS shows diffuse sensorimotor polyneuropathy; treat diabetes optimization, gabapentin/duloxetine for symptoms

— Generalized myopathy, slowed reflexes, weight gain; CTS is a known association via myxedematous infiltration

— Check TSH; treat with levothyroxine — CTS often improves

— Enlarged hands, jaw, shoes/rings; soft tissue hypertrophy compresses the median nerve

— IGF-1 elevated; pituitary MRI; treat the adenoma → CTS resolves

— AL amyloid (plasma cell dyscrasia): bilateral CTS, macroglossia, periorbital purpura, nephrotic syndrome, cardiomyopathy

— ATTR amyloid (wild-type or hereditary): older men, bilateral CTS preceding HFpEF, autonomic dysfunction, lumbar spinal stenosis

— Workup: serum/urine immunofixation, free light chains, NT-proBNP, echo, pyrophosphate scan, tissue biopsy

— Flexor tenosynovitis at wrist compresses median nerve; treat underlying RA

— Tophaceous deposits in the carpal tunnel; serum uric acid, aspirate crystals

— Fluid retention–mediated; usually reversible

Board pearl: A 68-year-old man with bilateral CTS, lumbar spinal stenosis, biceps tendon rupture, and HFpEF → classic wild-type ATTR amyloidosis. Order pyrophosphate scan, free light chains, and refer to cardiology/hematology.

Step 3 management: When CTS is bilateral and symmetric in a non-pregnant adult, always think systemic disease (DM, hypothyroidism, RA, amyloid, acromegaly) and screen accordingly — do not just splint and forget.

Diabetic peripheral polyneuropathy:

Hypothyroidism:

Acromegaly:

Amyloidosis:

Rheumatoid arthritis / connective tissue disease:

Gout / pseudogout:

Pregnancy and OCP/HRT use:

Hemodialysis-associated β2-microglobulin amyloidosis

Multiple myeloma, lymphoma infiltrating soft tissue

Vitamin B12 deficiency, alcohol-related neuropathy — diffuse, not focal

Carcinomatous neuropathy / paraneoplastic syndromes — rare

Secondary Prevention and Long-Term Plan

— Weight loss in obese patients (BMI ≥30): reduces CTS recurrence

— Glycemic control in diabetes: optimize HbA1c <7% when safe; reduces neuropathy progression

— Thyroid replacement in hypothyroidism: titrate to euthyroid state

— RA control: DMARDs to reduce tenosynovitis

— Treat acromegaly, amyloidosis when identified

— Neutral wrist position during keyboard/mouse use; ergonomic keyboard, wrist rests

— Frequent micro-breaks (every 30–60 minutes) and stretching

— Avoid prolonged forceful gripping, repetitive flexion/extension, vibratory tools

— Vibration-dampening gloves for occupational exposure

— Job rotation in industrial settings

— Hobbies (knitting, gaming, racquet sports) — alternate hands, take breaks

— Avoid sleeping on flexed wrists; nocturnal splinting if recurrent

— Hand therapy as needed for scar desensitization, strengthening, nerve gliding

— Return to work timeline: desk work 1–2 weeks; manual labor 4–6 weeks

— Address worker's compensation paperwork accurately

— Continue ergonomic and activity modifications indefinitely

— Maintain comorbidity control

— Patient education: recognize early recurrence signs and seek timely care

Step 3 management: A patient with CTS and BMI 35, HbA1c 8.2%, hypothyroidism (TSH 12) — beyond splinting, the long-term plan is weight loss counseling, intensify diabetes therapy (e.g., metformin + GLP-1 agonist), levothyroxine titration, and ergonomic counseling. This integrated approach earns full credit on CCS-style cases.

Board pearl: Vitamin B6 (pyridoxine) supplementation is not evidence-based for CTS prevention or treatment and may cause sensory neuropathy at high doses (>200 mg/day). Do not recommend.

Modifiable risk factor management — Step 3 emphasizes longitudinal care:

Ergonomic counseling:

Activity modification:

Post-surgical long-term plan:

Recurrence prevention:

Follow-Up, Monitoring, and Rehabilitation

— Reassess at 4–6 weeks after initiating splinting

— Improvement → continue splinting × additional 4–6 weeks, taper as symptoms resolve

— No improvement → escalate (steroid injection, NCS, surgical referral)

— Reassess at 6–12 weeks after corticosteroid injection

— Document symptom score (Boston Carpal Tunnel Questionnaire — symptom severity and functional status) for objective tracking

— Wound check and suture removal at 10–14 days

— Symptom assessment at 4–6 weeks: most patients have substantial improvement in nocturnal symptoms by 1–2 weeks; sensory recovery over weeks to months

— At 3 months: assess functional recovery, return to full activity

— At 6–12 months: maximal recovery for severe cases; consider revision if persistent

— Early postoperative: gentle active finger range of motion, edema control

— 2–6 weeks: scar mobilization, desensitization, nerve gliding exercises, gradual strengthening

— Beyond 6 weeks: return to occupational/recreational activities

— Set realistic expectations: nocturnal symptoms often resolve quickly; sensory and motor recovery may be incomplete in severe long-standing disease

— Reinforce ergonomic modifications and activity adjustments

— Discuss recurrence risk and when to return

— Annual symptom screen in high-risk patients (diabetics, dialysis, RA)

— Recheck NCS if symptoms recur or new neurologic deficits develop

Board pearl: After CTR, nocturnal paresthesias typically improve within days to a week. If they persist beyond 4–6 weeks, suspect incomplete release or alternative diagnosis (cervical radiculopathy) and re-evaluate.

Step 3 management: Standard follow-up cadence after surgical CTR: 2 weeks (wound), 6 weeks (function), 3 months (recovery) — questions sometimes hinge on choosing the right follow-up interval rather than escalation.

Conservative therapy follow-up:

Postoperative follow-up after CTR:

Hand therapy/rehabilitation:

Patient counseling at each visit:

Monitoring for recurrence:

Ethical, Legal, and Patient Safety Considerations

— Disclose realistic outcomes (70–90% improvement), risks (nerve/tendon injury, pillar pain, incomplete relief, CRPS, infection, scar tenderness), and alternatives (continued conservative therapy)

— Document specifically in patients with severe disease that some sensory/motor deficit may be permanent despite successful surgery

— Consider health literacy and language; use teach-back

— CTS is one of the most commonly reported work-related musculoskeletal disorders

— Document occupational exposure history thoroughly

— Provide accurate work restrictions; avoid both over- and under-restriction

— Familiarity with state worker's compensation rules is part of family medicine practice

— Maintain objectivity; do not function as both treating physician and disability evaluator without disclosure

— Severe CTS with hand weakness or numbness may impair grip and steering — counsel patient; postoperative driving usually resumed when off narcotics and able to grip

— At surgical referral, ensure communication of NCS results, prior conservative therapy, comorbidities, and anticoagulation status

— At hospital discharge after surgery (rare admission), ensure postoperative wound care instructions, follow-up appointment, and analgesic plan — opioid stewardship: limit to short course (3–5 days), prefer acetaminophen + NSAIDs as first-line

— Coordinate periprocedural anticoagulation interruption (warfarin, DOACs) with cardiology when indicated; CTR is generally low-bleeding-risk and many surgeons continue anticoagulation

— Workplace injury reporting per OSHA when work-related; document mechanism and exposures

Board pearl: A patient demands surgery immediately at first visit without trying conservative therapy. The ethical and clinically correct response is shared decision-making: explain that splinting and injection have meaningful success rates, surgery carries irreversible risks, and recommend a trial of conservative therapy unless severe disease is present. Respect patient autonomy but ensure informed consent.

Step 3 management: Always document the rationale for surgical referral, the conservative therapies attempted, and the informed-consent discussion — protects against malpractice claims and supports value-based care metrics.

Informed consent for carpal tunnel release:

Occupational disease and worker's compensation:

Driving safety:

Transition-of-care safety:

Anticoagulation management:

Mandatory reporting:

High-Yield Associations and Rapid-Fire Facts

Board pearl: The "OK sign" tests anterior interosseous nerve (FPL + FDP to index). Inability → AIN syndrome, not CTS.

Step 3 management: Memorize the cadence: splint → inject → operate. Skip steps only when severe disease, traumatic etiology, or rapid progression is present.

Median nerve sensory distribution: thumb, index, middle, radial half of ring finger — palm spared (palmar cutaneous branch arises proximal to the tunnel)

Motor: thenar muscles (LOAF = Lumbricals 1–2, Opponens pollicis, Abductor pollicis brevis, Flexor pollicis brevis)

Most sensitive provocative test: Durkan carpal compression (>Phalen >Tinel)

Flick sign: shaking the hand relieves symptoms — highly specific when volunteered

Most sensitive NCS abnormality: prolonged distal sensory latency (early), followed by motor latency, then amplitude reduction

Up to 25% of clinical CTS have normal NCS — treat the patient

Bilateral CTS in elderly man + HFpEF → think wild-type ATTR amyloidosis (high yield)

Bilateral CTS in pregnancy → splint, reassure, usually resolves postpartum

Pediatric bilateral CTS → mucopolysaccharidoses

Dialysis-associated CTS → β2-microglobulin amyloid

Acromegaly, hypothyroidism, RA, gout, DM — known risk factors

Ineffective for CTS (board distractors): oral NSAIDs, diuretics, pyridoxine, magnets, ultrasound therapy

First-line therapy: nocturnal neutral-position wrist splint × 4–6 weeks

Second-line: corticosteroid injection (methylprednisolone 40 mg)

Definitive therapy: surgical carpal tunnel release (open or endoscopic — equivalent at 1 year)

Indications for early surgery: thenar atrophy, motor weakness, denervation on EMG, acute traumatic CTS

Post-CTR pillar pain: lasts 6 weeks to 6 months; self-limited

Recurrent CTS post-release (5–15%): imaging + revision surgery

Workup of bilateral or atypical CTS: TSH, HbA1c, CBC, ESR, consider SPEP/UPEP/free light chains, NT-proBNP, echo

Cervical radiculopathy vs CTS: neck pain + Spurling + dermatomal pattern → radiculopathy

Pronator syndrome vs CTS: palm involved + no nocturnal symptoms → pronator syndrome

Board Question Stem Patterns

Board pearl: When the stem volunteers "the patient shakes the hand to relieve symptoms" — that's the flick sign, a highly specific clue locking in CTS.

Step 3 management: Read the stem for severity cues (atrophy, weakness, duration) — they determine whether the answer is splint, inject, image, or operate.

Stem 1 — Classic clinical diagnosis: 45-year-old typist with 3 months of nocturnal hand tingling in thumb, index, middle fingers; shakes hand for relief; positive Phalen. Next step? → Nocturnal neutral wrist splinting (not EMG, not injection, not surgery).

Stem 2 — Treatment escalation: Same patient returns after 6 weeks of splinting with persistent symptoms. Next step? → Corticosteroid injection into the carpal tunnel.

Stem 3 — Severe presentation: 60-year-old with thenar atrophy, constant numbness, dropping objects, denervation on EMG. Next step? → Refer for surgical carpal tunnel release (do not waste time on conservative therapy).

Stem 4 — Pregnancy: 30-week pregnant woman with bilateral nocturnal hand paresthesias. Next step? → Reassurance, ergonomic counseling, nocturnal wrist splinting; expect postpartum resolution.

Stem 5 — Atypical presentation: Patient with hand numbness including the palm and forearm pain with resisted pronation. Diagnosis? → Pronator syndrome, not CTS.

Stem 6 — Pediatric: Child with bilateral CTS, coarse facies, corneal clouding, hepatosplenomegaly. Diagnosis? → Mucopolysaccharidosis (Hurler/Hunter); refer for enzyme testing.

Stem 7 — Systemic: 68-year-old man with bilateral CTS, recent biceps tendon rupture, lumbar spinal stenosis, low-voltage ECG, HFpEF. Next step? → Pyrophosphate scan + free light chains for ATTR amyloid.

Stem 8 — Acute CTS: Anticoagulated patient with sudden hand pain and progressive median paresthesias after a fall. Next step? → Reverse anticoagulation, emergent hand surgery consult for decompression.

Stem 9 — Negative NCS: Classic CTS symptoms but normal nerve conduction studies. Next step? → Treat clinically; up to 25% of CTS has normal NCS. Initiate splinting.

Stem 10 — Post-op complication: 6 months after CTR, patient has severe burning pain, swelling, allodynia, color changes. Diagnosis? → CRPS; refer to pain medicine, start gabapentinoid + PT.

One-Line Recap

High-yield recap bullets:

Board pearl: The exam loves the bilateral-CTS-in-elderly-man-with-HFpEF → ATTR amyloidosis linkage and the splint-before-EMG, splint-before-inject, inject-before-operate cadence. Memorize both.

Step 3 management: Document conservative therapy trials, modifiable risk factor counseling, ergonomic recommendations, and informed consent at every encounter — these closed-loop longitudinal touches are the hallmark of high-quality outpatient family medicine and earn maximum CCS credit.

Carpal tunnel syndrome is a clinically diagnosed median neuropathy at the wrist, treated stepwise with nocturnal neutral-position wrist splinting, then corticosteroid injection, then surgical release — with electrodiagnostic studies reserved for atypical, severe, or preoperative cases, and a careful longitudinal search for treatable systemic contributors (diabetes, hypothyroidism, RA, pregnancy, amyloidosis).

Diagnosis is clinical — classic median-distribution nocturnal paresthesias with positive Durkan/Phalen/Tinel; palm spared. Up to 25% of CTS has normal NCS; treat the patient. Order NCS for atypical features, severity grading, or preoperative confirmation.

Step-wise management: nocturnal neutral wrist splint × 4–6 weeks → corticosteroid injection (methylprednisolone 40 mg) → surgical carpal tunnel release (open or endoscopic, equivalent at 1 year). Skip to surgery for thenar atrophy, motor weakness, denervation, or acute traumatic CTS.

Always screen for systemic contributors when bilateral or atypical: TSH, HbA1c, RA workup, pregnancy test, and in elderly men with HFpEF or unexplained features → ATTR amyloidosis workup (pyrophosphate scan, free light chains, NT-proBNP, echo). Treat the underlying disease alongside the nerve.

Special populations: pregnancy CTS — splint and reassure (resolves postpartum); pediatric bilateral CTS — think mucopolysaccharidoses; dialysis CTS — β2-microglobulin amyloid; diabetics — confirm injection plan and monitor glucose post-injection.